DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20210289

Platelet rich plasma following hysteroscopic adhesolysis: a randomized clinical trial

Mortada E. Ahmed, Mohamed I. Amer, Walaa E. Ahmed

Abstract


Background: Intrauterine adhesions (IUAs) is an uncommon condition that occurs after endometrial trauma, still it affects many women seeking fertility. Hystroscopic adhesolysis is the standard management procedure for IUAs, yet many concerns arise about the incidence of recurrence. This study evaluates the efficacy of Platelet rich plasma in decreasing adhesion recurrence following hystroscopic adhesolysis of severe intrauterine adhesions.

Methods: A prospective randomized clinical trial held in the Endoscopy Unit of Ain Shams University Hospital, Cairo, Egypt. 160 women with grade-III intrauterine adhesions, according to American Fertility Society criteria, were randomized to either receiving 5ml platelet rich plasma injection into the uterine wall in the most affected parts of the endometrium and lining the uterine cavity by 5ml platelet rich plasma gel followed by intrauterine insertion of folley’s catheter balloon left for two weeks (study group), or only insertion of folley’s catheter balloon for two weeks with injection of placebo solution and using placebo gel (control group). Second look office hysteroscopy was performed 3 months post-operative to assess the grade of intrauterine adhesions. The primary outcome was the incidence of recurrence of intrauterine adhesions. Secondary outcomes were the post-operative improvement of menstrual duration and flow, and pregnancy rate within 1 year post-adhesolysis.

Results: 70/81(86.4%) patients showed grade-I adhesions, 8/81 (9.9%) grade-II and 3/81 (3.7%) remained grade-III in the study group compared to 42/78 (53.8%) grade-I, 21/78 (26.9%) grade II and 15/78 (19.2%) grade-III in the control group (p<0.001).

Conclusions: Platelet rich plasma shows better improvement of adhesion score, menses duration and menses amount following hystroscopic dissection of severe intrauterine adhesions.


Keywords


Asherman’s syndrome, Adhesion recurrence, Hystroscopic adhesolysis, Intrauterine adhesions, Intrauterine synechia, Operative hysteroscopy, Platelet rich plasma

Full Text:

PDF

References


Nappi C, Di Spiezio Sardo A, Greco E, Guida M, Bettocchi S, Bifulco G. Prevention of adhesions in gynaecological endoscopy. Hum Reprod Update. 2007;13(4):379-94.

Khan Z, Goldberg JM. Hysteroscopic Management of Asherman’s Syndrome. J Minim Invasive Gynecol. 2018;25(2):218-28.

Yu D, Wong YM, Cheong Y, Xia E, Li TC. Asherman syndrome-one century later. Fertil Steril. 2008;89(4):759-79.

Deans R, Abbott J. Review of intrauterine adhesions. J Minim Invasive Gynecol. 2010;17(5):555-69.

Sahu L, Tempe A, Gupta S. Hysteroscopic evaluation in infertile patients: a prospective study. Int J Reprod Contracept Obstet Gynecol. 2012;1(1):37-41.

Shokeir TA, Fawzy M, Tatongy M. The nature of intrauterine adhesions following reproductive hysteroscopic surgery as determined by early and late follow-up hysteroscopy: clinical implications. Arch Gynecol Obstet. 2008;277(5):423-7.

Ventolini G, Zhang M, Gruber J. Hysteroscopy in the evaluation of patients with recurrent pregnancy loss: a cohort study in a primary care population. Surg Endosc. 2004;18(12):1782-4.

Lin XN, Zhou F, Wei ML, Yang Y, Li Y, Li TC, et al. Randomized, Controlled Trial Comparing the Efficacy of Intrauterine Balloon and Intrauterine Contraceptive Device in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis. Fertil Steril. 2015;104(1):235-40.

Amer MI, Abd-El-Maeboud KH. Amnion graft following hysteroscopic lysis of intra uterine adhesions. J Obstet Gynecol Res. 2006;32(6):559-66.

Amer MI, Abd-El-Maeboud KH, Abdelfatah I, Salama FA, Abdallah AS. Human amnion as a temporary biologic barrier after hysteroscopic lysis of severe intrauterine adhesions: pilot study. J Minim Invasive Gynecol. 2010;17(5):605-11.

Peng X, Li T, Zhao Y, Guo Y, Xia E. Safety and Efficacy of Amnion Graft in Preventing Reformation of Intrauterine Adhesions. J Minim Invasive Gynecol. 2017;24(7):1204-10.

Conforti A, Alviggi C, Mollo A, De Placido G, Magos A. The management of Asherman syndrome: a review of literature. Reprod Biol Endocrinol. 2013; 11:118.

Smith RG, Gassmann CJ, Campbell MS. Platelet-rich plasma: properties and clinical applications. J Lancaster Gen Hosp. 2007;2(2):73-8.

Chang Y, Li J, Chen Y, Wei L, Yang X, Shi Y, et al. Autologous platelet-rich plasma promotes endometrial growth and improves pregnancy outcome during in vitro fertilization. Int J Clin Exp Med. 2015;8(1):1286-90.

Amer M, Ahmed M, Kamal R, Torky A. The value of using platelet rich plasma after hystroscopic analysis of severe intrauterine adhesions (A randomized controlled trial). The Egyptian Journal of Hospital Medic. 2018;71(4):2869-74.

American Fertility Society. The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, müllerian anomalies and intrauterine adhesions. Fertil Steril. 1988;49(6):944-55.

Jo CH, Roh YH, Kim JE, Shin S, Yoon KS. Optimizing platelet-rich plasma gel formation by varying time and gravitational forces during centrifugation. J Oral Implantol. 2013;39(5):525-32.

March CM. Management of Asherman’s syndrome. Reprod Biomed Online. 2011;23(1):63-76.

Lin X, Wei M, Li TC, Huang Q, Huang D, Zhou F, et al. A comparison of intrauterine balloon, intrauterine contraceptive device and hyaluronic acid gel in the prevention of adhesion reformation following hysteroscopic surgery for Asherman syndrome: a cohort study. Eur J Obstet Gynecol Reprod Biol. 2013;170(2):512-6.

Cai H, Qiao L, Song K, He Y. Oxidized, Regenerated Cellulose Adhesion Barrier Plus Intrauterine Device Prevents Recurrence After Adhesiolysis for Moderate to Severe Intrauterine Adhesions. J Minim Invasive Gynecol. 2017;24(1):80-8.

Javaheri A, Kianfar K, Pourmasumi S, Eftekhar M. Platelet-rich plasma in the management of Asherman's syndrome: An RCT. Int J Reprod Biomed. 2020;18(2):113-20.